Impact News +++ Option Care Health appoints Meenal Sethna as CFO (SeekingAlpha) +++ OPTION CARE HEALTH Aktie -6,67%

ORION CORP Aktie

>ORION CORP Aktienkurs

69.3 EUR +1.7% (Tradegate)

Ask: 69.4 EUR / 600 Stück

Bid: 69.35 EUR / 600 Stück

Tagesumsatz: 61 Stück

Realtime Kurs von 8 bis 22 Uhr!

ORION CORP Aktie über LYNX handeln

Intraday

1 Jahr

>ORION CORP Performance

1 Woche: +3,0%

1 Monat: -1,6%

3 Monate: +18,8%

6 Monate: +30,5%

1 Jahr: +46,2%

laufendes Jahr: +59,3%

>ORION CORP Aktie

Name:

ORION CORP. B

Land:

Finnland

Sektor:

Gesundheit

ISIN/ Wkn:

FI0009014377 / A0J3QM

Symbol/ Ticker:

OFK (Frankfurt)

Kürzel:

FRA:OFK, ETR:OFK, OFK:GR

Index:

Webseite:

https://www.orion.fi/

Profil:

Orion Oyj is a leading Finnish pharmaceutical comp..
>Volltext..

Marktkapitalisierung:

9698.53 Mio. EUR

Unternehmenswert:

9832.67 Mio. EUR

Umsatz:

1693.07 Mio. EUR

EBITDA:

567.32 Mio. EUR

Nettogewinn:

381.37 Mio. EUR

Gewinn je Aktie:

2.71 EUR

Schulden:

320.74 Mio. EUR

Liquide Mittel:

185.24 Mio. EUR

Operativer Cashflow:

315.69 Mio. EUR

Bargeldquote:

0.34

Umsatzwachstum:

33.32%

Gewinnwachstum:

62.72%

Dividende je Aktie:

1.63 EUR

Dividendenrendite:

2.4%

Dividendenschätzung:

2.37%

Div. Historie:

04.04.25 - 0.82€
15.10.24 - 0.81€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

ORION CORP, ORION OYJ, ORION CORPORATION

Letzte Datenerhebung:

20.08.25

>ORION CORP Kennzahlen

Aktien/ Unternehmen:

Aktien: 108.38 Mio. St.

Frei handelbar: 97.28%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: 3712

Umsatz/Mitarb.: 0.37 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 1.02%

Bewertung:

KGV: 25.71

KGV lG: 25.94

KUV: 5.8

KBV: 10.58

PEG-Ratio: 0.41

EV/EBITDA: 17.33

Rentabilität:

Bruttomarge: 61.87%

Gewinnmarge: 22.53%

Operative Marge: 27.84%

Managementeffizenz:

Gesamtkaprendite: 24.36%

Eigenkaprendite: 44.96%

>ORION CORP Peer Group

Es sind 11 Aktien bekannt.

>ORION CORP Chart & Kurs - Tradegate

>ORION CORP News

20.08.25 - 08:03	337,000 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 AUGUST 2025 at 9.00 EEST ...

13.08.25 - 10:12	Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries (PR Newswire)
	OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark, following the earlier announcement on June 27th. Orion Corporation ("Orion"), the product......

13.08.25 - 09:54

Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries. (Cision)

Oslo, Norway – 2025.08.13 – Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark, following the earlier announcement on June 27th. Orion Corporation (“Orion”), the product licensor for Finland and the rest of the EU, has also obtained final confirmation for the Finnish market. "We are excited to have received the last approvals, paving the way for our go-to-market launch in the Nordic region," said Kathrine Gamborg Andreassen, Chief Executive Officer of Navamedic. Flexilev® in OraFID® ensures...

08.08.25 - 08:33	Orion Corporation: Managers′ transactions – Juhani Kankaanpää (GlobeNewswire EN)
	ORION CORPORATION MANAGERS' TRANSACTIONS 8 AUGUST 2025 at 9.30 EEST ...

04.08.25 - 15:12	Orion Corporation: Managers′ transactions – Satu Ahomäki (GlobeNewswire EN)
	ORION CORPORATION MANAGERS' TRANSACTIONS 4 August 2025 at 16:10 EEST ...

28.07.25 - 20:30	Here is Why Growth Investors Should Buy Orion OYJ (ORINY) Now (Zacks)
	Orion OYJ (ORINY) could produce exceptional returns because of its solid growth attributes....

21.07.25 - 09:33	Darolutamide receives EU approval in third indication for patients with advanced prostate cancer (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST ...

18.07.25 - 11:03	Orion Group Half-Year Financial Report January–June 2025 (GlobeNewswire EN)
	ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2025 18 JULY 2025 at 12:00 EEST...

18.07.25 - 08:33	Orion Corporation′s financial reporting and Annual General Meeting in 2026 (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 18 JULY 2025 at 9.30 EEST ...

11.07.25 - 20:30	Looking for a Growth Stock? 3 Reasons Why Orion OYJ (ORINY) is a Solid Choice (Zacks)
	Orion OYJ (ORINY) could produce exceptional returns because of its solid growth attributes....

09.07.25 - 12:03	Inside information: Orion upgrades full-year outlook for 2025 (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 9 JULY 2025 at 13.00 EEST ...

04.07.25 - 08:03	Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025 (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 4 JULY 2025 at 09.00 EEST ...

23.06.25 - 08:33	141,959 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 23 June 2025 at 9.30 EEST ...

17.06.25 - 08:03	Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 17 JUNE 2025 at 9.00 EEST ...

03.06.25 - 22:33	U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST ...

23.05.25 - 11:42	Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 23 MAY 2025 at 12.40 EEST ...

22.05.25 - 09:18	Orion to host Capital Markets Day today, 22 May 2025, in Helsinki (GlobeNewswire EN)
	ORION CORPORATION INVESTOR NEWS 22 MAY 2025 at 10.15 EEST ...

21.05.25 - 06:33	Orion′s collaborator, MSD, expands clinical development program for opevesostat to women′s cancers (GlobeNewswire EN)
	ORION CORPORATION INVESTOR NEWS 21 MAY 2025 at 07.30 EEST ...

08.05.25 - 15:33	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS8 May 2025 at 16:30 EEST ...

07.05.25 - 16:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 May 2025 at 17.00 EEST ...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Am Anfang war die Kraft. - Paula Modersohn-Becker

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram